A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)

NCT00552617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General

Interventions

DRUG: Sugammadex
DRUG: Placebo
DRUG: Rocuronium
DRUG: Vecuronium

Sponsor

Merck Sharp & Dohme LLC